baber/WOPTO huggingface dataset:
Patent AU-2001259270-B2 (AU)
Title: Methods and compositions utilizing quinazolinones
Inventor: FINER JEFFREY T
IPC: A61P35/00
Filed: 2001-04-27
Granted: 2006-08-24
Abstract: Quinazolinones of formulae (a, b, c and d) are disclosed. They are useful for treating cellular proliferative diseases and disorders associatged with KSP kinesin activity.
Patent AU-2001263484-B2 (AU)
Title: Methods of treating hepatitis delta virus infection with beta-l-2'- deoxy-nucleosides
Inventor: SOMMADOSSI JEAN-PIERRE
IPC: A61K31/7068
Filed: 2001-05-29
Granted: 2006-12-14
Abstract: A method and composition for treating a host infected with hepatitis D comprising administering an effective hepatitis D treatment amount of a described 2'-deoxy-beta-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof.
Patent AU-2001278604-B2 (AU)
Title: Polyketides and their synthesis
Inventor: LEADLAY PETER FRANCIS
IPC: C12N9/10
Filed: 2001-08-14
Granted: 2005-10-06
Abstract: Biosyntheses of compounds whereof at least portions are polyketides produced by means of polyketide synthase (PKS) enzyme complexes are carried out after specific alterations have been made within the acyltransferase (AT) domains of the PKSs. Particular motifs in or near the substrate binding pocket are disclosed, such that alterations therein affect substrate specificity.
Patent AU-2001280303-B2 (AU)
Title: Cellular antenna
Inventor: GRAHAM PETER BRUCE
IPC: H01P1/18
Filed: 2001-07-10
Granted: 2007-02-15
Abstract: An antenna control system comprises means (63) driving motive means (64 to 66). Motive means (64 to 66) may be suitably geared electrical motors or the like. Motive means (64) adjusts a variable differential phase shifter (70) to vary the downtilt of the beam of the antenna. Motive means (65) adjusts phase shifters (80, 81 and 82) via linkages (69) to adjust the azimuth of the beam of the antenna. Motive means (66) adjusts power dividers (54 to 56) via linkages (68) to adjust beam width of the beam of the antenna.
Patent AU-2001284688-B2 (AU)
Title: Coordinated satellite-terrestrial frequency reuse
Inventor: OLEXA RONALD
IPC: H04W16/14
Filed: 2001-08-01
Granted: 2006-07-06
Abstract: A system and method of operation for efficiently reusing and/or sharing at least a portion of the frequency spectrum between a first satellite spot beam and a second satellite spot beam, and/or an underlay terrestrial network associated with a second satellite spot beam. The spectrum is efficiently reused and/or shared between respective spot beams and/or associated underlay terrestrial systems in a manner minimizes interference between the respective satellite and terrestrial systems.
Patent AU-2001295058-B2 (AU)
Title: Drying method for selectively removing volatile components from wet coatings
Inventor: KOLB WILLIAM BLAKE
IPC: A61K31/439
Filed: 2001-09-21
Granted: 2006-06-22
Abstract: Method of selectively removing volatile components from a composition, comprising coating the composition onto a first substrate surface of a substrate, wherein the composition comprises a nonresident volatile component and a resident volatile component. The method further includes positioning at least a portion of the coated substrate between a condensing surface having a condensing surface temperature and a heating surface having a heating surface temperature that is greater than the condensing surface temperature, wherein the condensing surface is in a spaced apart, confronting relationship to the coated surface of the substrate and wherein the heated surface is in thermal contact with a second substrate surface opposite the first substrate surface. In the method, the heated surface temperature and the condensing surface temperature are such that the positioning step causes the nonresident volatile component to be selectively removed from the portion of the coated substrate. The method is suitable for forming transdermal drug delivery compositions.
Patent AU-2001296701-B2 (AU)
Title: Simplified quality indicator bit test procedures
Inventor: CHEN TAO
IPC: H04B7/005
Filed: 2001-10-06
Granted: 2006-03-02
Abstract: In a code division multiple access communication system, a method and apparatus provide for an efficient testing of operating behavior of a quality indicator bit. The method and the accompanying apparatus include configuring a receiver to expect to receive a communication channel at a full data rate, and transmitting a signal from a transmitter to the receiver. The signal is carrying the communication channel at a data rate other than said full data rate, and at a power level for receiving at the full data rate. Consequently, the receiver fails to receive the communication channel at the full data rate. A received signal to noise ratio of the received signal at the receiver is determined. A value of the quality indicator bit is determined based on the determined signal to noise ratio. The determined value of the quality indicator bit is communicated to the transmitter.
Patent AU-2001297692-B2 (AU)
Title: Apparatus for the treatment of dental caries
Inventor: LYNCH EDWARD
IPC: A61C19/00
Filed: 2001-11-05
Granted: 2005-10-20
Abstract: Apparatus for the treatment of dental caries includes a source of oxidizing gas and a handpiece for delivering the gas to a tooth. A cup attached to the handpiece is provided for receiving the gas and exposing a selected area of the tooth to the gas. The cup includes a resilient edge for sealably the edge for engaging the tooth around the selected area to prevent escape of a gas therepast. <IMAGE>
Patent AU-2002316850-B2 (AU)
Title: Method and device for regulating pressure in a single-screw degassing extruder or in a cascade extruder
Inventor: SCHAFER BERNHARD
IPC: B29C48/76
Filed: 2002-04-15
Granted: 2006-11-09
Abstract: The invention relates to a method for regulating the minimal value of the pressure in the first half of the metering zone in a direction of conveyance in a single-screw degassing extruder or in a cascade extruder during the conveying of a melt consisting of a thermoplastic. The single-screw degassing extruder or the cascade extruder each have a first screw section ( 13 ), a degassing zone ( 14 ), a metering zone ( 22 ), and a measuring control loop (M), which includes a pressure measuring sensor (P) in the first half of the metering zone, a regulator (R) and an actuator (S) for influencing the pressure in the metering zone. The pressure is measured by the pressure measuring sensor (P) and is set by the regulator (R) and the actuator (S) so that the minimal value at the location of measurement ranges from 0.1 to 10 bar.
Patent AU-2002365056-B2 (AU)
Title: Electrotransport device having an integrally molded reservoir housing
Inventor: GRACE MICHAEL JOSEPH
IPC: H01R11/01
Filed: 2002-12-20
Granted: 2007-07-26
Abstract: This invention relates to an electrotransport device, which incorporates a conductive element within the reservoir housing of the device, which permits electrical communication from within the housing to outside of the housing without the use of opening, which require various methods of sealing the openings against leaks and moisture.
Patent AU-2003201396-B2 (AU)
Title: Magnesium-zirconium alloying
Inventor: JOHN DAVID ST
IPC: C22B26/22
Filed: 2003-01-20
Granted: 2007-08-23
Abstract: Zirconium sponge can be chemically depassivated by treatment with hydrofluoric acid to improve the ability of molten magnesium/magnesium alloy to dissolve zirconium from the treated zirconium sponge and to form a melt containing substantially evenly distributed particles of zirconium. Optical micrographs showing the grain refining ability of pretreated sponge when added to pure magnesium at 680° C. All micrographs are of the same magnification. (a) Pure magnesium, (b) after adding 1 wt % sponge followed by 20 minutes manual stirring, and (c) after a further 10 minutes stirring.
Patent AU-2003255711-B2 (AU)
Title: Biologically active compounds
Inventor: RAY PETER CHRISTOPHER
IPC: C07D498/04
Filed: 2003-07-15
Granted: 2008-11-13
Abstract: Compounds of general formula (I) wherein Z=CR<SUP>3</SUP>R<SUP>4</SUP>, where R<SUP>3 </SUP>and R<SUP>4 </SUP>are independently chosen from C<SUB>0-7</SUB>-alkyl P<SUB>1</SUB>=CR<SUP>5</SUP>R<SUP>6</SUP>, P<SUB>2</SUB>=O, CR<SUP>7</SUP>R<SUP>8 </SUP>or NR<SUP>9</SUP>, Y=CR<SUP>10</SUP>R<SUP>11</SUP>-C(O) or CR<SUP>10</SUP>R<SUP>11</SUP>-C(S) or CR<SUP>10</SUP>R<SUP>11</SUP>-S(O) or CR<SUP>10</SUP>R<SUP>11</SUP>-SO<SUB>2</SUB>(X)<SUB>0</SUB>=.CR<SUP>16</SUP>R<SUP>17 </SUP>(W)<SUB>n</SUB> =0 , S, C(O), S(O) or S(O)<SUB>2</SUB>- or NR<SUP>18</SUP>(V)<SUB>m</SUB>=C(O), C(S), S(O), S(O)<SUB>2</SUB>, S(O)<SUB>2</SUB>NH, OC(O), NHC(O), NHS(O), NHS(O)<SUB>2</SUB>, OC(O)NH, C(O)NH or CR<SUP>19</SUP>R<SUP>20</SUP>, C-N-C(O)-OR<SUP>19 </SUP>or C-N-C(O)-NHR<SUP>19</SUP>, U=a stable. 5- to 7 membered monocyclic or a stable 8- to 11-membered bicyclic ring which is either saturated or unsaturated, and which includes zero to four heteroatoms and their sales, hydrates, solvates, complexes and prodruges are inhibitors of cathepsin K and other cysteine protease inhibitors and are useful as therapeutic agents, for example in osteoporosis, Paget's disease gingival diseases such as gingivitis and periodontis, hypercalaemia of malignancy, metabolic bone disease, diseases involving matrix or cartilage degradation, in particular osteoarthitis and rheumatoid arthritis and neoplastic diseases. The compounds are also useful for validating therapeutic target compounds.
Patent AU-2003293675-B2 (AU)
Title: Recombinant poxvirus comprising at least two cowpox ATI promoters
Inventor: HOWLEY PAUL
IPC: C12N15/863
Filed: 2003-11-12
Granted: 2009-04-23
Abstract: Recombinant poxvirus are disclosed comprising in the viral genome at least two expression cassettes, each comprising a cowpox ATI promoter according to SEQ ID NO:1, a polynucleotide sequence in which not more than 6 nucleotides are substituted, deleted, and/or inserted into SEQ ID NO:1 and still active as an ATI promoter, or a polynucleotide comprising at least 10 nucleotides including nucleotides 22 to 29 of SEQ ID NO: 1 and still active as an ATI promoter and a coding sequence, wherein the expression of the coding sequence is regulated by said promoter or said polynucleotides. The recombinant poxviruses are useful as pharmaceutically active ingredients in the preparation of vaccines.
Patent AU-2004207050-B2 (AU)
Title: Ambient temperature curing coating composition
Inventor: NIXON STEVE ALISTER
IPC: C08F/
Filed: 2004-01-26
Granted: 2008-09-18
Abstract: Ambient temperature curing coating composition comprising-a branched alkoxy-functional polysiloxane having the formula R2-O-[Si(R1)<SUB>2</SUB>-O]<SUB>n</SUB>-R2, wherein each R1 is selected from the group consisting of alkyl, aryl, and alkoxy groups having up to six carbon atoms, and Osi(OR3)<SUB>3 </SUB>groups, wherein each R3 independently has the same meaning as R1, each R2 is selected from the group consisting of hydrogen and alkyl and aryl groups having up to six carbon atoms, and wherein n is selected such that the molecular weight of the polysiloxanes is in the range of from 500 to about 2,000,-a catalyst, and-an acrylic polymer. The acrylic polymer is substantially free of functional groups that can react with the polysiloxane or with the catalyst in the coating composition.
Patent AU-2005204259-B2 (AU)
Title: Methods of preparing substituted tetracyclines with transition metal-based chemistries
Inventor: RENNIE GLEN
IPC: C07C231/12
Filed: 2005-08-25
Granted: 2009-07-16
Abstract: The present invention relates to novel chemistries which allow for heretofore unobtainable substituted tetracycline compounds which exhibit significant antibacterial activity. The methods disclosed herein utilize reactive tetracycline-based precursor compounds, reactive organic substituent precursors and transition metal catalysts under conditions such that a tetracycline compound substituted with the desired organic substituent is formed. In one embodiment of the invention, a substituted tetracycline compound may be prepared by combining a reactive tetracycline-based precursor compound such as an arene tetracycline diazonium salt, and a reactive organic substituent precursor, e.g., alkenes, substituted alkenes, vinyl monomers, aromatics and heteroaromatics, in the presence of a transition metal catalyst, such as palladium chloride, under conditions such that a tetracycline compound substituted with the organic substituent is formed. Such compounds may optionally act as intermediates for making other compounds, e.g., hydrogenation of unsaturated groups on the substituent.
Patent AU-2005232693-B2 (AU)
Title: Treatment of ophthalmic conditions with mineralcorticoids
Inventor: ROBERT SANDERS DONALD
IPC: A61K31/56
Filed: 2005-04-08
Granted: 2012-01-12
Abstract: The present invention provides a method of treatment of an individual with an ophthalmic condition comprising the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound is an anti-oedematous steroid, more preferably a mineralocorticoid.
Patent AU-2005302448-B2 (AU)
Title: Therapeutic furopyrimidines and thienopyrimidines
Inventor: BABU YARLAGADDA S
IPC: C07H19/22
Filed: 2005-10-28
Granted: 2012-07-19
Abstract: The invention provides compounds of formula I, II, and III as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of formula I, II, and III are useful as anti-viral agents and/or as anti-cancer agents.
Patent AU-2006229967-B2 (AU)
Title: Novel compounds
Inventor: WAN ZEHONG
IPC: A61K31/519
Filed: 2006-03-24
Granted: 2012-02-09
Abstract: Novel substituted l,5,7-trisubstituted-354-dihydro-pyriinido[4,5-(flpyrimidin- 2-(2H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
Patent AU-2006233200-B2 (AU)
Title: A vacuum assembly
Inventor: CHADWICK DARRYL
IPC: E21F5/08
Filed: 2006-10-26
Granted: 2012-08-23
Abstract: A VACUUM ASSEMBLY Abstract A vacuum assembly (1) including a body (5) to be secured to a vehicle. A cyclone chamber (10) attached to the body (5) and having an air inlet (15) and an air 5 outlet (20). A suction assembly (25) is attached to the outlet (20) to draw air therefrom to cause air to flow through the chamber (10) in an angular manner to separate particles from the air. A particle collecting receptacle (35) disposed at a lower part of the cyclone chamber (10) for collecting the separated particles. The receptacle (35) providing for removal of collected particles. A grill member (40) between the chamber (10) and io suction assembly (25) to inhibit particles above a predetermined size from flowing through the air outlet (20). A suction nozzle (43) extending to the inlet (15) so as to deliver air thereto and including a head (45) operable to reduce in size at least some of the particles delivered to the air inlet (15). JoN (NJJ
Patent AU-2006242950-B2 (AU)
Title: Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3 -receptor ligands
Inventor: SCHWARTZ JEAN-CHARLES
IPC: C07D401/10
Filed: 2006-04-25
Granted: 2013-01-10
Abstract: The present patent application concerns new compounds of formula (I), their process of preparation and their therapeutic use.
Patent AU-2006266149-B2 (AU)
Title: Devices, systems, and methods for creation of a peripherally located fistula
Inventor: BRENNEMAN RODNEY
IPC: A61B17/34
Filed: 2006-06-26
Granted: 2012-04-12
Abstract: Devices, systems and methods are disclosed for the formation of an arteriovenous fistula in the limb of the patient. Embodiments include a device (10) for the creation, modification and maintenance of a fistula that includes an integral fistula creation assembly (25) near its distal end that passes through the skin of the patient, through a first vessel such as an artery, and into a second vessel such as a vein. The fistula creation assembly (25) preferably includes an anastomotic implant (60) that is placed within the fistula t maintain long term blood flow there through. The devices, systems and methods can be used to treat patients with one or more numerous ailments including chronic obstructive pulmonary disease, congestive heart failure, hypertension, hypotension, respirator failure, pulmonary arterial hypertension, lung fibrosis and adult respiratory distress syndrome.
Patent AU-2006271511-B2 (AU)
Title: Bed castor and brake assembly
Inventor: HAYES STEPHEN
IPC: A61G7/00
Filed: 2006-07-17
Granted: 2012-02-23
Abstract: A pedal (10) is formed from a single moulding and includes first and second arms (12, 14), each provided with an over moulded marker (16, 18). The pedal (10) has two fittings (20, 22) for coupling with a brake actuator rod (24) and a coupling member (26) respectively. A castor (40) includes a wheel (42) which can rotate about a bushing (44) and a coupling shaft (46). Within the shaft (46) there is provided a brake mechanism for locking the wheel (42). A base frame (80) for a bed includes longitudinal and transverse struts (52, 54) arranged in a rectangular form, with four castors (40) and four associated pedal assemblies (10). Two actuator rods (24) are provided, one for each pair of opposing pedal assemblies (10), while two connecting elements (26) are provided, one for each pair of side-by-side pedal assemblies (10). All the pedals and thus all the brake mechanisms are coupled to one another through the two actuator rods (24) and two coupling elements (26). When one pedal (10) is actuated all the castors will either be locked or will all be released by a single operation.
Patent AU-2006290259-B2 (AU)
Title: Mower head with protection for a cutting cord
Inventor: ARNETOLI FABRIZIO
IPC: A01D34/416
Filed: 2006-09-11
Granted: 2012-03-22
Abstract: The mower head (1) includes a body (3) with at least one exit hole (9A) for one end of a cutting cord (F) and includes, adjacent to the exit hole of the cutting cord and on at least one side of said hole, a radial projection (11) to protect the cutting cord.
Patent AU-2006299874-B2 (AU)
Title: Method for determining chlorine demand in water
Inventor: RIGSBY KAREN
IPC: C02F1/76
Filed: 2006-08-31
Granted: 2012-04-19
Abstract: Methods for determining chlorine demand in water are provided. One method comprises (a) providing a test water sample containing at least one contaminant and a source of chlorine and a source of bromide; (b) heating the test water sample for a suitable time and temperature sufficient to substantially oxidize the at least one contaminant in the test water sample; and (c) determining the content of residual chlorine present in the test water sample.
Patent AU-2006301847-B2 (AU)
Title: Composite nanoparticles, nanoparticles and methods for producing same
Inventor: EMINA VELETANLIC
IPC: C09D7/65
Filed: 2006-10-13
Granted: 2011-11-17
Abstract: In various aspects provided are methods for producing a nanoparticle within a cross-linked, collapsed polymeric material, said method including (a) providing a polymeric solution comprising a polymeric material; (b) collapsing at least a portion of the polymeric material about one or more precursor moieties; (c)cross-linking the polymeric material; (d) modifying at least a portion of said precursor moieties to form one or more nanoparticles and thereby forming a composite nanoparticle. In various embodiments, a non-confined nanoparticle can be produced by complete pyrolysis of the confined nanoparticle, and a carbon-coated nanoparticle by incomplete pyrolysis of the confined nanoparticle.
Patent AU-2007202715-B2 (AU)
Title: Aerosol apparatus, in particular for children
Inventor: ZAMBON ELENA
IPC: A61M15/00
Filed: 2007-06-13
Granted: 2013-04-18
Abstract: An aerosol apparatus comprising a nebulizer device and a mask suitable for receiving a substance substantially in the sol state from the nebulizer device 5 is described. The apparatus also comprises a display device able to display a sequence of images to a patient while he/she is using the apparatus. The display device may be a DVD player which conveniently is able to be separated from 10 the aerosol apparatus. The apparatus is particularly suitable for use by patients who are children. (Fig. 2) \rnelbfiles\DocStore\Melbourne\Cases\Patent\72000-72999\P72261 AU\Speas\P72261 AU GHSPEC doc 13/06/07
Patent AU-2007211150-B2 (AU)
Title: System and method for selectively stimulating different body parts
Inventor: TRACEY MICHAEL R
IPC: A61N1/36
Filed: 2007-01-26
Granted: 2012-01-19
Abstract: A device and method for transdermally stimulating selected body parts of a mammal which includes a first waveform generator for generating a first waveform having a first frequency capable of stimulating a first predetermined body part, a second waveform generator for generating a carrier waveform having a second frequency capable of passing through tissue of the mammal, and a third waveform generator for generating a third waveform having a third frequency different from and out of phase with that of the first waveform, and capable of stimulating a second predetermined body part. A modulation device is electrically coupled to the first, second and third waveform generators and modulates the carrier, first, and third waveforms to create a modulated signal package. A first electrode is electrically coupled to the modulation device and positioned substantially adjacent to the skin of the mammal to apply the modulated signal package thereto.
Patent AU-2007222667-B2 (AU)
Title: Phospholipid complexes of curcumin having improved bioavailability
Inventor: GIORI ANDREA
IPC: A61K31/685
Filed: 2007-02-21
Granted: 2012-11-08
Abstract: The present invention relates to novel phospholipids complexes of curcumin or extracts containing it having improved bioavailability.
Patent AU-2007255732-B2 (AU)
Title: Sense oligonucleotide capable of controlling the expression of iNOS and composition comprising the same
Inventor: OKUMURA TADAYOSHI
IPC: A61P19/02
Filed: 2007-06-07
Granted: 2014-04-03
Abstract: Disclosed is a sense oligonucleotide for controlling the expression of iNOS (inducible nitric oxide synthase), which has a sequence complementary to single-stranded RNA (an antisense transcript) having a nucleotide sequence complementary to mRNA of iNOS gene. The sense oligonucleotide can be used for controlling the expression of iNOS, and is useful for biological defense or the treatment or prevention of a disease associated with the excess production of NO, such as cancer, an inflammatory disease and endotoxin shock induced by bacterial infection.
Patent AU-2007267958-B2 (AU)
Title: Vector controlled leveling system for a forestry machine
Inventor: O'HALLORAN JAMES
IPC: B60G23/00
Filed: 2007-05-23
Granted: 2012-04-05
Abstract: The present invention provides a leveling control system for a forestry machine employing position sensors that relay information about the orientation of the carriage in relation to the swing-house assembly in order to control roll and pitch in a manner that maximizes the operating envelope of the leveling mechanism. The angles of pitch and roll of the swing-house assembly in relation to the carriage are measured and/or calculated and a controller limits operation of the leveling mechanism to an operating envelope that may be described in terms of pitch and roll. The cylinders are decelerated gradually as the operating envelope is approached. The controller can include an automatic leveling mode. The controller can change the function of the fore, aft, left and right operator controls so that they are true from the operator's frame of reference regardless of the rotary position of the cab relative to the carriage.